A subscription to JoVE is required to view this content. Sign in or start your free trial.
We developed and describe a protocol based on the wet spinning concept, for the construction of gelatin-based biomaterials used for the application of tissue engineering.
This article presents an inexpensive method to fabricate gelatin, as a natural polymer, into monofilament fibers or other appropriate forms. Through the wet spinning method, gelatin fibers are produced by smooth extrusion in a suitable coagulation medium. To increase the functional surface of these gelatin fibers and their ability to mimic the features of tissues, gelatin can be molded into a tube form by referring to this concept. Examined by in vitro and in vivo tests, the gelatin tubes demonstrate a great potential for application in tissue engineering. Acting as a suitable filling gap material, gelatin tubes can be used to substitute the tissue in the damaged area (e.g., in the nervous or cardiovascular system), as well as to promote regeneration by providing a direct replacement of stem cells and neural circuitry. This protocol provides a detailed procedure for creating a biomaterial based on a natural polymer, and its implementation is expected to greatly benefit the development of correlative natural polymers, which help to realize tissue regeneration strategies.
The latest development in tissue regeneration involves the application of tissue engineering, which represents a challenge for the improvement of new therapeutic strategies in medical treatments. For example, the limited potential of nervous system regeneration, following injury or disease, poses a significant health problem worldwide. Due to the complexity of pathophysiological processes associated with the nervous system, the use of traditional autograft or the implementation of stabilization surgery has been shown to offer benefits in functional outcomes, but there is no strong evidence for the effects of spinal fixation surgery1,....
The fat tissues were obtained from orthopedic surgeries as certified by the Institutional Review Board of Tri-Service General Hospital, Taipei, Taiwan, R.O.C. Procedures involving animal subjects have been approved by the Animal Care Committee at National Defense Medical Center, Taiwan (R.O.C).
1. Wet Spinning Process
In this study, we successfully developed the gelatin into fibers (Figure 2A) and tubes (Figure 2B,C) through the user-friendly wet spinning concept. These gelatin-based materials can be utilized as any medical tool, depending on their shapes. Considering that the functional surface and frame of such materials are more suitable for tissue regeneration, we examined the biocompatibility of gelatin t.......
We presented the development of gelatin-based biomaterials by using a simple wet spinning technique that can be applied in the study of natural polymers for tissue regeneration. This work demonstrated the possibility of gelatin fabrication as a great protein source without the addition of other sources, with the aim to optimize the properties of gelatin itself. The development of gelatin-based biomaterials was entirely carried out in room temperature (22 - 26 °C). A gentle solution preparation is a critical step wit.......
This study was supported by the Ministry of National Defense (MAB-105-070; MAB-106-077; MAB-107-032; MAB-107-065), the Ministry of Science and Technology (MOST 107-2320-B016-016), Tri-Service General Hospital, the National Defense Medical Center, Taiwan (TSGH-C106-046; TSGH-C106-115; TSGH-C107-041), and Cheng-Hsin General Hospital and National Defense Medical Center Cooperation (CH-NDMC-107-8).
....Name | Company | Catalog Number | Comments |
Solution preparation: | |||
Gelatin type B (porcine) | Ferak | Art. -Nr. 10733 | 500 g vial |
Wet spinning process: | |||
Peristaltic pump | Gilson | Model M312 | Minipuls*3 |
Plastic tube connector | World Precision Instruments | 14011 | 1 box |
Syringe | Sterican | 5A06258541 | 26Gx1/2"(0.45 x 12mm) |
Acetone | Ferak | Art. -Nr. 00010 | 2.5 L vial |
Polycaprolactone CAPA 6500 | Perstorp | 24980-41-4 | - |
Dichloromethane | Scharlau | CL03421000 | 1 L vial |
Glass Pasteur pipette | Fisher Scientific | 13-678-20A | - |
Hemostat | Shinetec instruments | ST-B021 | - |
Peripheral venous catheter (Introcan Certo) | B. Braun | 1B03258241 | 24Gx3/4"(0.7 x 19mm) |
Morphology of the gelatin tube: | |||
Ion sputter coater machine | Hitachi | e1010 | - |
Scanning electron microscopy | Hitachi | S-3000N | - |
Cultivation of cells on the gelatin tube: | |||
Trypsin-EDTA | Gibco | 488625 | 100 mL vial |
Fetal bovine serum | Gibco | 923119 | 500 mL vial |
Dulbecco's modified Eagle's medium | Gibco | 31600-034 | Powder |
Keratinocyte-SFM medium | Gibco | 10744-019 | 500 mL vial |
T25 culture flask | TPP | 90025 | VENT type |
6-well plate | Falcon | 1209938 | - |
Immunocytochemistry: | |||
Phospate-buffered saline | Gibco | 654471 | 500 mL vial |
Acetic acid glacial | Ferak | Art. -Nr. 00697 | 500 mL vial |
NP-40 surfactant (Tergitol solution) | Sigma | 056K0151 | 500 mL vial |
Normal goat serum | Vector Laboratories | S-1000-20 | 20 mL vial, concentrate |
Nestin (primary antibody) | Santa Cruz Biotechnology | SC-23927 | - |
Donkey anti-mouse-fluorescein isothiocyanate (secondary antibody) | Santa Cruz Biotechnology | SC-2099 | - |
Hoechst 33342 | Anaspec | AS-83218 | 5 mL vial |
In vivo biocompatibility test: | |||
Tiletamine+zolazepam | Virbac | BC91 | 5 mL vial |
Xylazine | Bayer korea | KR03227 | 10 mL vial |
Ketoprofen | Astar | 1406232 | 2 mL vial |
Povidone-iodine solution | Everstar | HA161202 | 4 L barrel |
Cefazolin | China Chemical & Pharmaceutical | 18P909 | 1 g vial |
Scalpel blade | Shinetec instruments | ST-B021 | - |
Surgical scissor | Shinetec instruments | ST-B021 | - |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved